Francisco Vega

Professor of Clinical

  • 3916 Citations
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2019

Erratum: CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis (Cancer Cell (2018) 33(6) (1111–1127.e5), (S1535610818302216), (10.1016/j.ccell.2018.05.007))

Greenblatt, S. M., Man, N., Hamard, P. J., Asai, T., Karl, D., Martinez, C., Bilbao, D., Stathias, V., Jermakowicz, A. M., Duffort, S., Tadi, M., Blumenthal, E., Newman, S., Vu, L., Xu, Y., Liu, F., Schurer, S. C., McCabe, M. T., Kruger, R. G., Xu, M. & 5 others, Yang, F. C., Tenen, D. G., Watts, J., Vega, F. & Nimer, S. D., Jan 14 2019, In : Cancer Cell. 35, 1, p. 156 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2018

Erratum: CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis (Cancer Cell (2018) 33(6) (1111–1127.e5), (S1535610818302216) (10.1016/j.ccell.2018.05.007))

Greenblatt, S. M., Man, N., Hamard, P. J., Asai, T., Karl, D., Martinez, C., Bilbao, D., Stathias, V., McGrew-Jermacowicz, A., Duffort, S., Tadi, M., Blumenthal, E., Newman, S., Vu, L., Xu, Y., Liu, F., Schurer, S. C., McCabe, M. T., Kruger, R. G., Xu, M. & 5 others, Yang, F. C., Tenen, D., Watts, J., Vega, F. & Nimer, S. D., Nov 12 2018, In : Cancer Cell. 34, 5, p. 868 1 p.

Research output: Contribution to journalComment/debate

Intracytoplasmic azurophilic inclusions in prolymphocytes

Mackrides, N., Lossos, I. & Vega, F., Dec 1 2018, In : International Journal of Hematology. 108, 6, 1 p.

Research output: Contribution to journalComment/debate

2017
2013

"cup-like" blasts and NPM1 and FLT3 (ITD) mutations in acute myeloid leukemia (AML)

Jain, P., Vega-Vazquez, F. & Faderl, S., Jul 1 2013, In : International Journal of Hematology. 98, 1, 1 p.

Research output: Contribution to journalComment/debate

4 Scopus citations

Time to look for CD30 expression in diffuse large B-cell lymphomas, along the way to immunotherapy

Vega, F., Oct 21 2013, In : Leukemia and Lymphoma. 54, 11, p. 2341-2342 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2010

V(D)J recombination and staggered DNA breaks: Guilty again

Vega, F. & Medeiros, L. J., Mar 18 2010, In : Blood. 115, 11, p. 2121-2122 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2008

An attractive therapeutic target, mTOR pathway, in ALK+ anaplastic large cell lymphoma

Cho-Vega, J. H., Vega, F. & Medeiros, L. J., Mar 1 2008, In : Advances in anatomic pathology. 15, 2, p. 105-112 8 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2005

Erratum: Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles (Modern Pathology (2005) 18 (806-815) 10.1038/modpathol.3800355)

Vega, F., Chang, C. C., Medeiros, L. J., Udden, M. M., Cho-Vega, J. H., Lau, C. C., Finch, C. J., Vilchez, R. A., McGregor, D. & Jorgensen, J. L., Jun 1 2005, In : Modern Pathology. 18, 6, 1 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2001
20 Scopus citations